Form 4: Olema Pharmaceuticals Director Sells Shares
Insider Transaction (Form 4)
Cyrus Harmon, a Director of Olema Pharmaceuticals, Inc., sold 25,000 shares of common stock on July 23, 2026.
Summary
- Open-market sale: disposed of 12,500 Common Stock at $11.58 ($144,738) on July 23, 2026; holds 715,270 after (Direct).
- Open-market sale: disposed of 12,500 Common Stock at $11.71 ($146,425) on July 24, 2026; holds 702,770 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $291,162 of stock on the open market.
Insider Transactions
Cyrus Harmon — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Open-market sale | Common Stock | 12,500 | $12 | $144.7K | 715,270 |
| 2026-07-24 | Open-market sale | Common Stock | 12,500 | $12 | $146.4K | 702,770 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Open-market sale (12,500 shares) |
| 2026-07-24 | Open-market sale (12,500 shares) |
Keywords
insider transaction, Form 4, OLMA, Olema Pharmaceuticals, Inc., bearish, Cyrus Harmon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.